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Abstract
Helminth parasites secrete extracellular vesicles (EVs) that can be internalised by host
immune cells resulting in modulation of host immunity. While the molecular cargo of EVs have
been characterised in many parasites, little is known about the surface-exposed molecules
that participate in ligand-receptor interactions with the host cell surface to initiate vesicle dock-
ing and subsequent internalisation. Using a membrane-impermeable biotin reagent to capture
proteins displayed on the outer membrane surface of two EV sub-populations (termed 15k and
120k EVs) released by adult F. hepatica, we describe 380 surface proteins including an array
of virulence factors, membrane transport proteins and molecules involved in EV biogenesis/
trafficking. Proteomics and immunohistochemical analysis show that the 120k EVs have an
endosomal origin and may be released from the parasite via the protonephridial (excretory)
system whilst the larger 15k EVs are released from the gastrodermal epithelial cells that line
the fluke gut. A parallel lectin microarray strategy was used to profile the topology of major sur-
face oligosaccharides of intact fluorogenically-labelled EVs as they would be displayed to the
host. Lectin profiles corresponding to glycoconjugates exposed on the surface of the 15 K and
120K EV sub-populations are practically identical but are distinct from those of the parasite sur-
face tegument, although all are predominated by high mannose sugars. We found that while
the F. hepatica EVs were resistant to exo- and endo-glycosidases, the glyco-amidase PNGase
F drastically remodelled the surface oligosaccharides and blocked the uptake of EVs by host
macrophages. In contrast, pre-treatment with antibodies obtained from infected hosts, or puri-
fied antibodies raised against the extracellular domains of specific EV surface proteins (DM9-
containing protein, CD63 receptor and myoferlin), significantly enhanced their cellular internali-
sation. This work highlights the diversity of EV biogenesis and trafficking pathways used by F.
hepatica and sheds light on the molecular interaction between parasite EVs and host cells.
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Author summary
Over the last decade, it has become recognised that extracellular vesicles (EVs) are impor-
tant mediators of communication by transferring molecular signals (including proteins,
lipids, complex carbohydrates, mRNA, microRNA and other non-coding RNA species),
between cells. Variously described as exosomes or microvesicles depending on their cellu-
lar origin and mode of biogenesis, EVs perform a variety of roles in the maintenance of
normal physiology but also participate in pathological settings. EVs also play an important
role in host-pathogen interactions, with recent work suggesting that they contribute to
helminth immunomodulatory strategies. Here we have identified the proteins and sugars
displayed on the outer surface of two sub-types of EVs released by the helminth pathogen
Fasciola hepatica. We show that the proteins are antigenic and direct EV internalisation
by host macrophages. Our study provides a better understanding of how parasite-derived
EVs interact with host cells which is important for future development of therapeutics/
vaccines that target this interface.
Introduction
Helminth infections have a major impact on human and animal health in many parts of the
world. Indeed, up to one third of the global human population [1] and>50% of the world’s
livestock play host to helminth parasites [2]. Helminths cause chronic infections and their per-
sistence within their mammalian hosts is due, in part, to their striking ability to avoid/modu-
late the host immune response. We, and others, have previously shown that the liver fluke
Fasciola hepatica secretes several immunomodulatory molecules with multiple mechanisms of
action. These include peroxiredoxin that stimulates the development of M2 macrophages
[3,4], cathepsin L1 that degrades toll-like receptor 3 within the endosome of macrophages [5]
and helminth defence molecule (HDM) that impairs antigen processing and presentation by
macrophages by inhibition of vATPase [6]. Secretion of these soluble proteins and shedding of
glycoproteins/proteins expressed on the tegumental surface [7,8] was previously thought to be
the sole route of export for F. hepatica antigens. However, it is now recognised that the parasite
also releases extracellular vesicles (EVs) as a mechanism for non-canonical secretion of pro-
teins and other molecules [9,10].
Parasite-derived EVs can be internalised by host immune cells resulting in a range of intra-
cellular signalling events that have potent immunomodulatory effects [11]. The major advan-
tage for the parasite with such a mechanism of export and delivery is the ability to package a
large array of (perhaps complementary) effector molecules in a protective environment. Thus,
protein and RNA molecules that would otherwise be susceptible to degradative enzymes in the
host extracellular microenvironment are protected and can exert their biological effects at sites
distant from their site of release.
Little is known about the mechanism of uptake of EVs by host cells and whether the process
is mediated by specific molecular interactions or by more passive means. One explanation for
this is the lack of knowledge pertaining to the molecules specifically displayed on the surface of
parasite-derived EVs that could mediate uptake by host cells via initial interaction with plasma
membrane receptors. Studies using EVs, derived from various mammalian cell types, have
shown that their internalisation by recipient cells can be influenced by both surface-exposed
proteins and their post-translational modifications, notably glycosylation [12]. To fully under-
stand the transfer of EV-packaged parasite molecules to host cells, which would facilitate the
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design of therapeutic blocking agents, it is critical that we identify the cohort of proteins that
are exposed on the outer membrane surface of parasite EVs and the displayed EV surface
glycosylation.
We have previously shown that F. hepatica releases at least two EV sub-populations (termed
15k and 120k EVs) that differ according to size and cargo molecules [10,13]. In this study, we
used a membrane-impermeable biotin reagent to label the EV surface and then mass spec-
trometry to identify the labelled proteins of both EV sub-populations. Fluorescently labelled
EVs were profiled by multiplexed lectin microarrays to examine the topology of the major car-
bohydrate motifs presented to the host. Our proteomics and immunohistochemical studies
indicate that the 15k EVs originate within the parasite gut whereas the 120k EVs may be
released from the excretory system. We also demonstrate that F. hepatica EV proteins are rec-
ognised by host antibodies, with the strength of the host response dependent on the timing of
infection. Pre-treatment of both 15k and 120k EVs with host antisera enhanced their uptake
by macrophages, an effect that could be replicated using antibodies raised against specific EV
surface proteins including DM9 protein, myoferlin and CD63 receptor. The results represent
the most definitive characterisation of the surface architecture of EVs from any parasite species
to date, and provides a template for a greater understanding of the interactive mechanism(s)
between parasite-derived EVs and recipient host cells.
Methods
Isolation of adult F. hepatica extracellular vesicles
Adult F. hepatica parasites were obtained from sheep livers from local abattoirs. To prepare
secretions, adult flukes were thoroughly washed with PBS to void their gut contents and to
remove any host contaminants and then maintained in RPMI-1640 culture medium contain-
ing 0.1% glucose, 100 U penicillin and 100 μg/ml streptomycin (Sigma-Aldrich), at 1 worm/ml
(typically in groups of 50 parasites) for 5 h at 37˚C. Whilst other methods, such as gradient
centrifugation, are increasingly used for EV isolation, we specifically used the differential cen-
trifugation protocol described by Marcilla et al. [9] to specifically characterise the F. hepatica
15k and 120k EVs we previously isolated using this method [10]. Briefly, after the incubation
period, the parasite culture media was collected and centrifuged at 300 x g for 10 min and then
at 2000 x g for 30 min to remove eggs, cells and large debris. The resulting supernatant was
centrifuged at 15,000 x g for 45 min at 4˚C to obtain large vesicles (15k EVs). Culture superna-
tants were then filtered using a 0.2 μm ultrafiltration membrane, and centrifuged at 120,000 x
g for 1 h at 4˚C to recover smaller vesicles (120k EVs). Both, 15k and 120k EVs were subse-
quently washed with PBS and immediately used for surface biotin labelling or snap frozen and
stored at -80˚C for further experiments.
Surface biotinylation of F. hepatica EVs and streptavidin pulldown
Freshly collected EVs were immediately incubated with a solution containing 1 mg/ml of
sulfo-NHS-LC-biotin (ThermoFisher Scientific) in PBS (pH 7.4) for 30 min at 4˚C. To prevent
hydrolysis of the sulfo-NHS-LC-biotin, the reagent was prepared immediately before use.
After labelling, excess biotinylation reagent was neutralized by incubating EVs with 50 mM
Tris–HCl in PBS for 15 min at 4˚C. Biotinylated samples were subsequently centrifuged either
at 15,000 x g for 45 minutes or 120,000 x g/1 h at 4˚C to remove the quenching solution.
Labelled EVs were then resuspended in PBS and stored at -80˚C until use. The same proce-
dure, excluding the biotin reagent, was followed to prepare non-biotinylated control EVs. Pro-
teins of biotinylated and non-biotinylated EVs were sequentially extracted in three steps with
200 μl of lysis buffer (0.1% SDS, 1% Triton X-100, in 50 mM Tris, pH 7.4) containing
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CompleteMini protease inhibitor cocktail (Roche Diagnostics). For each extraction, samples
were sonicated three times for 10 sec in a water bath sonicator. Samples were then incubated
on ice for 30 min with brief vortexing every 5 min and finally centrifuged at 20,500 x g for 30
min at 4˚C. Solubilized proteins were pooled and extracts of biotinylated and non-biotinylated
EVs were incubated separately with streptavidin–sepharose beads (GE Healthcare) for 1 h at
room temperature. The beads were washed four times with 400 μl of 50mM NH4HCO3, pH
8.0 and proteins digested with 5 ng/μl sequencing grade trypsin (Promega) overnight at 37˚C.
Finally, beads were transferred to a filter device (Millipore) and peptides recovered by centrifu-
gation at 5,000 x g for 1 min.
Mass spectrometry analysis of biotinylated proteins
Three biological replicates of the F. hepatica 15k and 120k EVs were biotinylated and analysed
by LC-MS/MS. Non-biotinylated negative controls were also analysed (in triplicate) for each
sample. Tryptic peptides were dried in a vacuum centrifuge and reconstituted with 10 μl of
0.1% TFA before analysis by LC-MS/MS. Five μl of the resulting suspension were delivered to
an analytical column (Eksigen C18-CL NanoLC Column, 3 μm; 75 μm x 15 cm) equilibrated
in 5% acetonitrile/0.1% formic acid (FA). Elution was carried out with a linear gradient of
5–35% buffer B in buffer A for 30 min (buffer A: 0.1% FA; buffer B: acetonitrile, 0.1% FA) at a
flow rate of 300 nl/min. Peptides were analysed in a nanoESI QqTOF mass spectrometer (5600
TripleTOF, ABSCIEX) operating in information-dependent acquisition mode, in which a
0.25-s TOF MS scan from 350–1250 m/z, was performed, followed by 0.05-s product ion scans
from 100–1500 m/z on the 50 most intense 2–5 charged ions. Peak list files were generated by
Protein Pilot v4.5 (Applied Biosystems) using default parameters and exported to Mascot
v2.4.1 (Matrix Science) for database searching.
Database searching
All MS/MS samples were analysed using Mascot v2.4.1 (Matrix Science). Mascot was set up to
search a database comprised of the gene models identified within the F. hepatica genome (ver-
sion 1.0, 101,780 entries; accession PRJEB6687 [14]) assuming trypsin digestion with 1 missed
cleavage permitted. Mascot was searched with a fragment ion mass tolerance of 0.60 Da and a
parent ion tolerance of 10.0 ppm. Carbamidomethylation of cysteine was specified in Mascot
as a fixed modification. Gln->pyro-Glu of the N-terminus, oxidation of methionine, dioxida-
tion of methionine, acetyl of the N-terminus, BHAc of lysine and NHS-LC-Biotin of the N-ter-
minus were specified in Mascot as variable modifications. An additional search against the
NCBI database or Ovis aries gene models (http://www.ensembl.org/Ovis_aries/Info/Index)
was run to identify potential host proteins.
Criteria for protein identification
Scaffold (version Scaffold_4.7.5, Proteome Software Inc., Portland, OR) was used to validate
MS/MS based peptide and protein identifications. Peptide identifications were accepted if they
could be established at greater than 95.0% probability by the Scaffold Local FDR algorithm.
Protein identifications were accepted if they could be established at greater than 99.0% proba-
bility and contained at least 2 identified peptides. Protein probabilities were assigned by the
Protein Prophet algorithm [15]. Proteins that contained similar peptides and could not be dif-
ferentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsi-
mony. Proteins sharing significant peptide evidence were grouped into clusters.
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Filtering of potential affinity chromatography contaminants and
construction of the final dataset
The following criteria were used to filter the MS/MS results. Firstly, only proteins with two or
more unique peptides reported in at least two of the three replicates were considered for fur-
ther analysis. In order to remove background contaminants subsequent to affinity chromatog-
raphy, proteins identified for each EV population were submitted to the CRAPome repository
[16] by selecting all available streptavidin-agarose experiments and our non-biotinylated EVs
as controls. Significance analysis of interactome (SAINT) score [17] was employed to set the
threshold (at 0.66). Additionally, a quantitative analysis was performed in Scaffold using a t-
test (Benjamini-Hochberg correction; significance level, p<0.05) as statistical method and
emPAI as quantitative method. Normalization was performed with zero as minimum value.
Those proteins below the SAINT threshold and/or reported as enriched in the non-biotiny-
lated EVs by Scaffold’s quantitative profile were removed as potential contaminants present
due to non-specific interaction with the streptavidin-agarose.
Immunoblot analysis of F. hepatica EVs
Antibodies to specific F. hepatica EV surface molecules were prepared in rabbits against
peptides derived from the external domains of tetraspanin-CD63 receptor (CD63rec;
GAKFTHKDSAAGRT), DM9 domain-containing protein (DM9; MYRHQQPAREVS), myo-
ferlin (MYO; GEPKRAPENIQLRD), PDCD6IP (Alix; TSSKKRPAPDRPPP), acid sphingo-
myelinase (aSMase; IEKGNDEGYAENKP), TSG101 (KSYKYARDVTNDVK) and Ral-A
(NKIDLTQERTVPFE) (GenScript, NY, USA). The protein content of the fluke EVs was deter-
mined using the BCA protein assay kit (Pierce). Equal amounts (10 μg) of each sample were
run on reducing NuPAGE Novex 4–12% Bis-Tris gels (Life Technologies), and transferred to
nitrocellulose membranes (GE Healthcare) at 120 mA for 45 min. Following transfer, the
membranes were incubated in blocking solution (TBST1: 20 mM Tris–HCl, 150 mM NaCl,
1% Tween 20, pH 7.6) containing 5% skimmed milk for 2 h at room temperature (18–21˚C).
Blots were probed with 0.5–1.0 μg/ml of the peptide antibodies or a 1:100 dilution of rat-anti-
serum taken at time-points (0, 7, 21 and 70 days) post-infection with F. hepatica for 2 h at
room temperature. After washing in TBST1 (3×10 min), an appropriate alkaline phosphatase-
conjugated IgG secondary antibody was applied to the membranes for 1 h at room tempera-
ture before detection using the BCIP/NBT substrate (Sigma-Aldrich).
Immunofluorescence microscopy
Adult F. hepatica were fixed with 4% PFA in 0.1 M PBS (Sigma-Aldrich) overnight at 4˚C and
subsequently embedded in JB-4 resin (Sigma-Aldrich). Semi-thin sections, 2 μm thick, were
cut on a pyramitome and mounted on clean glass slides. For immunofluorescence, JB-4 sec-
tions were washed with PBS and then incubated in 10 μg/ml of anti-FhCD63rec or anti-
FhRAL-A in antibody diluent (AbD: PBS containing 0.2% (v/v) Triton X-100) or a 1 in 500
dilution in AbD of rabbit anti-serum raised against recombinant F. hepatica cathepsin L1 over-
night at 4˚C. As a negative control, comparable sections were incubated in rabbit pre-immune
serum. The sections were then washed three times in AbD before incubation in a 1 in 100 dilu-
tion of the secondary antibody, fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit
IgG (Sigma-Aldrich), in AbD for 1 h at room temperature. Following three washes in PBS, the
sections were mounted in glycerol containing 10% (v/v) PBS and 0.1 M propyl gallate (Sigma-
Aldrich) then viewed under a Leica DM2500 fluorescent microscope. Leica type N immersion
oil was used in viewing and all images taken at room temperature.
The surface of Fasciola hepatica extracellular vesicles
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007087 January 18, 2019 5 / 27
Fluorescent labelling of FhTeg protein and EVs
The tegumental surface of adult F. hepatica (FhTeg) was extracted and labelled with Alexa
Fluor NHS succinimidyl ester 555 (ThermoFisher Scientific) as previously described [18,19].
F. hepatica 15k and 120k EVs were fluorescently labelled with the lipophilic dye PKH26
(Sigma-Aldrich) as previously reported [20]. Following labelling, excess dye was removed
from EVs using a 100 kDa MWCO spin device (EMD-Millipore).
Enzymatic modification of F. hepatica EV surface oligosaccharides
Five to fifty units (determined empirically for each enzyme) of exo-glycosidase (Jack bean α-
mannosidase, Sigma-Aldrich; β-galactosidase from bovine testes, Sigma-Aldrich), endo-glyco-
sidase (endo-β-N-acetylglucosaminidases Endo Tv [21] and Endo H, Roche), and glyco-ami-
dase (N-glycoamidase F, PNGase F) were used to modify the surface glycosylation of the EVs.
Each enzyme was added to 1 μg of PKH26-labelled EVs (total protein content) in 200 mM
sodium phosphate buffer including protease inhibitors (Roche) at pH 4.5 for α-mannosidase
and β-galactosidase, pH 5.5 for endoglycosidases and pH 7.4 for glyco-amidase treatment. The
reactions, and enzyme-free negative controls, were incubated in the dark for 14 h at 37˚C. In
parallel, the activity of β-galactosidase and PNGase F were verified by digestion of bovine
fetuin under the same conditions used for the EVs. Similarly, the activity of Endo H, Endo Tv
and α-mannosidase were verified by digestion with bovine RNAse B.
Profiling of fluorescently-labeled EVs with lectin microarrays
Lectin microarrays were performed in at least biological duplicate. Titrations with fluores-
cently labelled vesicles revealed that the optimal concentration range for EV loading was 0.6 to
1.0 μg/mL based on the signal to noise ratio and overall image quality. Following titrations,
experiments including multiple technical replicates (n = 3 at minimum) were carried out with
PKH26-labeled EVs (0.8 μg/ml total protein concentration). Lectin microarrays were con-
structed as previously described [20,22]. Briefly, 48 lectins, supplemented with 1 mM of their
respective haptenic sugar to maintain binding site integrity were printed on Nexterion H
(Schott) functionalized glass slides at 20˚C and 62% (+/-2%) relative humidity using a sci-
FLEXARRAYER S3 non-contact spotter (Scienion, Berlin, Germany). Unoccupied functional
groups were rendered inert by exposure to 100 mM ethanolamine in 50 mM sodium borate,
pH 8.0, for 1 h. Microarrays were washed in PBS with 0.05% Tween 20 (PBST) three times and
once with PBS, centrifuged dry (450 x g, 5 min) and stored at 4˚C with desiccant until use.
During titration, microarray slides were incubated with PKH26-labelled FhEVs (0.08–5.0 μg/
ml) diluted in buffer containing 20 mM Tris-HCl, 100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2
(pH 7.4) with 0.025% Tween 20 (TBST2) for 40 min at 23˚C. Slides were then washed in
TBST2 for 2 min, rinsed with TBS before drying by centrifugation (450 x g for 5 min). The
slides were then imaged immediately using the 532 nm (Cy3) channel of an Agilent G2505B
microarray scanner. All experiments included a control glycoconjugate in a separate subarray
to monitor performance of the arrays and imaging equipment. To confirm that the lectin-EV
interactions were carbohydrate mediated, select sugars (lactose (Lac), α-methylmannose
(αManOMe), and N-acetyl-D-glucosamine (GlcNAc) were also introduced as competitive
inhibitors (50 mM final concentration) of EV binding in discrete subarrays.
Microarray data extraction and analysis
Local background-corrected intensity values were extracted from the image files using Gene-
Pix Pro v6.1.0.4 (Molecular Devices) and evaluated in a manner similar to Gerlach et al. [20].
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The median of 6 replicate spots per sub-array was handled as a single data point for graphical
and statistical analysis. Unsupervised, hierarchical clustering of EV-lectin binding data was
performed with Hierarchical Clustering Explorer v3.0 (http://www.cs.umd.edu/hcil/hce/hce3.
html). Previously normalized data (all enzyme treatments; total intensity mean adjustment) or
raw data scaled inside HCE (FhEV vs FhTeg/ 0 to 30,000 relative fluorescence intensity (RFU))
for EVs was clustered with the following parameters: no pre-filtering, average linkage, Euclid-
ean distance. Statistical significance of lectin binding inhibition by competition with soluble
mono- or disaccharides was established by unpaired, two-tailed Student’s t-tests (with unequal
variance) of individual lectin data sets in Excel (Microsoft).
Macrophage uptake assays
PKH26-dyed EVs were incubated with either serum from F. hepatica-infected rats (0, 7, 21
and 70 days post-infection) or anti-EV antibodies at 1:100 dilution at 4˚C overnight. Unbound
antibodies were removed by centrifugation and the EV pellets were re-suspended in PBS.
RAW264.7 cells were allowed to attach to μ-Slide 8-well chambered coverslips (Ibidi) over-
night and the following day they were transferred to DMEM supplemented with exosome-
depleted FBS (Gibco) and 1% L-glutamine. Cells were incubated with 5 μg per well of
PKH26-dyed EVs (control) or antibody-coated EVs for 3 hours at 37˚C with 5% CO2. In some
experiments, cells were incubated with EVs in the presence of 2μg/ml cytochalasin D (Ther-
moFisher Scientific). Cells were washed three times in PBS and then fixed with 4% PFA,
washed in PBS, counterstained with DAPI and mounted in glycerol containing 10% (v/v) PBS
and 0.1 M propyl gallate (Sigma-Aldrich). Slides were examined using a Leica SP5 confocal
microscope (Leica Microsystems) with LAS AF software (Leica). Fluorescence was quantified
using ImageJ. At least 8 fields were analysed per experiment and a 1-way ANOVA was
performed.
Results
The surface-exposed proteome of EVs secreted by adult F. hepatica
To identify the proteins displayed on the outer surface of F. hepatica EVs, intact vesicles were
incubated with a membrane-impermeable biotin reagent, sequentially extracted and the bioti-
nylated proteins were captured by affinity chromatography using streptavidin-agarose beads
(S1 Fig). On-column trypsin digestion was performed, and the resulting peptides were ana-
lysed by LC–MS/MS against the F. hepatica gene models [14]. Only proteins with two or more
unique peptides in at least two of the three biological replicates were accepted. In parallel, non-
biotinylated EVs were subjected to the same procedure and quantitative and statistical analysis
with these controls allowed the detection of potential contaminants, which were removed
from the biotinylated dataset.
Using this approach, 380 individual proteins were identified, of which, 180 are shared by
15k and 120k EV populations; 155 proteins were exclusive to the 15k EVs, whereas 45 proteins
were present in the 120k EVs only (Fig 1A; S1 Table). Enrichment analysis of Gene Ontology
(GO) terms, highlighted exosomes, cytoplasm, lysosomes and plasma membrane as the most
abundant terms for both EV populations and subsequent protein domain analysis supported
the presence of membrane and membrane-associated proteins (S2 Fig). Indeed, membrane
proteins such as pumps, channels and transporters, were amongst the most abundant func-
tional groups identified in the F. hepatica EVs (Table 1) which validates the biotin labelling
and membrane extraction methods used in this study.
Several cysteine, serine and metallo- peptidases were found on the EV surface. Of the cyste-
ine peptidases, cathepsin Bs were of similar abundance in both EV sub-populations whilst
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cathepsin L1, L2 and a cathepsin D-like aspartic protease were enriched in the 15k EVs
(Table 2). Whilst the metallo-peptidases were generally more abundant on the surface of the
15k EVs, leucine aminopeptidases were found in both vesicle populations [10]. A number of
protease inhibitors (serpins, cystatin and a multi-domain cystatin) were also found in the sur-
face-biotinylated proteins of both the 15k and 120k EVs (Table 2). Other dominant functional
groups of EV surface proteins included signalling proteins (including a large number of mole-
cules responsive to calcium enriched in the 15k EVs), metabolic enzymes, receptors and carrier
proteins (S1 Table).
MS/MS data was also searched against the Ovis aries genome to identify any host proteins
associated with the EV surface. No host proteins were associated with the 120k EVs; however,
several were identified using the 15k MS/MS data including annexin, ceruloplasmin, HSP70,
vitronectin and valosin-containing protein.
Fig 1. Qualitative and quantitative proteomic analyses of 15k EVs and 120k EVs released by adult F. hepatica
suggest different intracellular origins of the EV sub-populations and identify specific surface proteins. (A) Venn
diagram showing the distribution of proteins qualitatively identified in the 15k and 120k EVs (>2 matched peptides in
at least 2 out of 3 replicate samples). (B) The 180 surface proteins that were expressed by both the 15k and 120k EVs
were subjected to quantitative analysis shown as a Volcano plot. The x-axis represents log2(fold-change) (15k/120k
EVs) and the y-axis shows the −log10 (p value). The dashed red line indicates the significance threshold (p = 0.05). The
vertical dashed black line indicates zero fold change. Green boxes represent proteins whose expression is significantly
different between the two EV sub-populations whilst the orange circles represent proteins that did not significantly
change. The position of proteins selected for further analysis by Western blot are shown. (C) Equal amounts (10μg
total protein) of 15k and 120k EVs were analysed by Western blot using antibodies raised against F. hepatica proteins
identified on the EV surface by LC-MS/MS. The relative expression patterns of the target proteins follows that of the
quantitative proteomics analysis.
https://doi.org/10.1371/journal.pntd.0007087.g001
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Qualitative and quantitative proteomics analysis suggests different modes
of biogenesis of the F. hepatica EV sub-populations
Extensive proteomics analysis was performed on three biological replicates of the biotin-
bound surface protein fractions of the F. hepatica EVs. In addition to the 155 and 45 proteins
that were unique to the 15k and 120k EVs respectively, 180 proteins were common to both ves-
icle sub-populations (Fig 1A). A label-free quantitative approach (based on emPAI values) was
Table 1. Membrane transport proteins found on the surface of F. hepatica EVs.
Protein name Gene ID t-test (p value) emPAI 15k emPAI 120k
Pumps
ABC subfamily B1 (MDR/TAP) BN1106_s274B000296 0.0077 0.429 0.934
ABC subfamily D4 (ALD) BN1106_s3396B000087 0.0021 0.916 4.974
Multidrug resistance protein 1 BN1106_s2471B000098 0.0017 0.383 1.637
Ca2+ transporting ATPase BN1106_s577B000267 0.38 0.045 0.095
Cation-transporting ATPase BN1106_s181B000525 0.001 0.000 0.151
Cation-transporting ATPase BN1106_s181B000526 0.0092 0.398 0.000
H+ transporting ATPase BN1106_s3321B000106 0.01 0.056 0.644
Na+/K+ transporting ATPase BN1106_s521B000167 0.0031 0.565 1.342
Phospholipid-transporting ATPase BN1106_s253B000145 0.24 0.010 0.044
Phospholipid-transporting ATPase BN1106_s626B000339 0.0033 0.046 0.236
Phospholipid-transporting ATPase BN1106_s435B000243 0.013 0.103 0.798
Phospholipid-transporting ATPase BN1106_s435B000242 0.0069 0.000 0.173
Na+/K+ ATPase BN1106_s3547B000116 0.73 0.136 0.099
Vacuolar H+ ATPase BN1106_s2593B000233 0.16 0.037 0.317
V-ATPase subunit B BN1106_s1633B000182 0.037 0.287 0.055
V-ATPase subunit I BN1106_s18772B000008 0.017 0.759 2.201
V-ATPase subunit I BN1106_s4862B000066 0.0043 0.099 0.312
V-ATPase subunit C BN1106_s2545B000160 0.00084 0.086 0.000
V-ATPase subunit H BN1106_s2350B000136 0.00026 0.208 0.000
Channels
Cation channel M4 BN1106_s1307B000310 0.0014 0.000 0.127
Chloride channel protein 7 BN1106_s2830B000084 0.12 0.000 0.056
Transporters
Anion exchange protein BN1106_s1377B000259 0.12 0.000 0.064
Anoctamin BN1106_s1581B000120 0.027 0.187 0.441
Cation/chloride co-transporter BN1106_s639B000758 0.12 0.065 0.143
Glucose transporter 3 BN1106_s584B000348 0.061 0.088 0.136
Glucose transporter 5 BN1106_s2815B000111 0.18 0.000 0.231
Cationic amino acid transporter 1 BN1106_s2234B000252 0.0019 0.043 0.244
Cationic amino acid transporter 1 BN1106_s1B000532 0.0088 0.263 0.000
Inositol transporter BN1106_s3611B000052 0.00035 0.000 0.193
Phosphatidylinositol transfer protein BN1106_s1214B000318 0.0023 0.175 0.000
Permease 1 heavy chain BN1106_s3721B000192 0.095 0.161 0.047
Phosphatidylcholine transfer protein BN1106_s538B000493 0.088 0.103 0.225
Putative amino acid permease BN1106_s1490B000080 0.024 0.207 0.657
Putative sodium/solute symporter BN1106_s1326B000429 0.083 1.107 2.519
Solute carrier family 2 member 3 BN1106_s584B000350 0.014 0.304 0.813
Solute carrier family 43 member 3 BN1106_s6088B000072 0.086 0.063 0.210
https://doi.org/10.1371/journal.pntd.0007087.t001
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used to determine the respective levels of these shared proteins. Volcano plot representation of
the relative abundance of EV proteins identified several proteins of the ESCRT pathway, and
others involved in vesicle trafficking that were significantly (p< 0.05) enriched in the 120k
EVs. These included IST1, RAL-A, TSG101, PDCD6IP (Alix) and CD63 receptor. A further
three ESCRT proteins (STAM-binding protein, CHMP1A and CHMP2A) were exclusive to
the 120k EVs (Table 3). In contrast, proteins involved in plasma membrane remodelling
(annexins, phospholipase A2, Na+/H+ exchange regulatory cofactor NHE-RF2), proteases,
cytoskeletal and cytosolic proteins were significantly enriched (p< 0.05) in the 15k EVs (Fig
1B; Tables 2 and 3; S1 Table). These results indicate that 120k EVs are derived from the endo-
somal compartment, whereas 15k EVs originate from the cytoplasm, hence carrying more
cytoskeletal/proteases/cytosolic proteins.
To validate the label-free quantitative proteomics analysis, equal amounts of the 15k and
120k EVs (10 μg) were probed with specific antibodies raised against selected surface proteins
Table 2. Proteases and protease inhibitors found on the surface of F. hepatica EVs.
Protein name Gene ID t-test (p value) emPAI 15k emPAI 120k
Cysteine peptidases
Cathepsin B6/8 BN1106_s793B000177 0.099 1.840 1.231
Cathepsin B4/5/7 BN1106_s13444B000002 0.46 1.099 1.543
Cathepsin B3 BN1106_s1772B000188 0.57 0.124 0.180
Cathepsin L1 BN1106_s10332B000011 0.036 0.082 0.018
Cathepsin D-like aspartic protease BN1106_s2719B000195 0.0016 0.076 0.000
Cathepsin L2 BN1106_s8098B000020 < 0.00010 0.116 0.000
Calpain BN1106_s204B000249 0.019 0.844 0.565
Calpain B BN1106_s368B000158 0.0052 0.170 0.023
Calpain 4/6/7 BN1106_s2697B000090 0.0065 0.393 0.000
Calpain 7 BN1106_s1630B000272 0.0026 0.040 0.199
Legumain-4/5 BN1106_s1861B000097 0.11 0.598 0.773
Serine peptidases
Carboxypeptidase C BN1106_s1241B000264 0.012 0.410 0.787
Pro-X carboxypeptidase BN1106_s1620B000120 0.038 0.126 0.345
Acylaminoacyl-peptidase BN1106_s3345B000120 0.0007 0.068 0.000
Mastin BN1106_s5880B000098 0.88 0.117 0.101
Metallo peptidases
Leucine aminopeptidase 2 BN1106_s617B000566 0.029 1.803 0.879
Leucine aminopeptidase BN1106_s5268B000042 0.0033 4.759 0.403
Aminopeptidase P1 BN1106_s997B000230 0.13 0.033 0.000
Xaa-Pro dipeptidase BN1106_s468B000343 0.002 1.039 0.615
Nardilysin BN1106_s2211B000138 0.019 0.098 0.000
Dipeptidyl-peptidase III BN1106_s13034B000002 0.12 0.032 0.000
Thimet oligopeptidase BN1106_s8350B000044 0.12 0.089 0.000
Protease inhibitors
Serpin 7 BN1106_s3864B000104 0.076 0.347 0.074
Serpin B6 BN1106_s1727B000096 0.41 0.478 0.624
Serpin B BN1106_s4618B000050 0.066 0.243 0.557
Serpin B6 BN1106_s122B000261 0.5 0.457 0.554
Serpin B BN1106_s3226B000049 0.49 0.210 0.355
Cys1 protein BN1106_s1612B000138 0.00011 0.051 0.000
Cystatin-1 BN1106_s4651B000094 0.24 1.448 1.938
https://doi.org/10.1371/journal.pntd.0007087.t002
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Table 3. Proteins associated with EV biogenesis and vesicle trafficking found on the surface of F. hepatica EVs.
Protein name Gene ID t-test (p value) emPAI 15k emPAI 120k
ESCRT components
STAM binding protein BN1106_s2325B000322 0.14 0.000 0.169
TSG101 BN1106_s410B000432 0.0052 0.080 0.352
CHMP2A BN1106_s912B000169 0.0045 0.000 0.980
CHMP1A BN1106_s2655B000264 0.047 0.000 1.393
CHMP1B BN1106_s2316B000077 0.0081 0.111 1.570
IST1 BN1106_s3747B000112 0.00025 0.073 1.136
VPS4B BN1106_s1437B000141 0.031 0.088 0.719
VTA1 BN1106_s2858B000111 0.31 0.117 0.363
ALIX BN1106_s1871B000313 0.003 0.169 1.578
BROX BN1106_s2963B000136 0.00057 0.101 0.722
Small GTPases
Rab GDP dissociation inhibitor BN1106_s605B000204 0.096 0.202 0.578
Rho GDP-dissociation inhibitor 2 BN1106_s4672B000098 0.0082 0.187 1.400
Rab-11B BN1106_s844B000259 0.028 0.308 1.151
Rab-35 BN1106_s2985B000113 0.2 0.323 0.378
Rab GDP dissociation inhibitor alpha BN1106_s605B000203 0.0063 0.143 0.000
Rab-3B BN1106_s3297B000203 0.77 0.406 0.502
Ral-A BN1106_s637B000246 0.021 0.000 0.868
Ras-related protein BN1106_s2124B000372 0.23 0.000 0.427
Rho-Gap protein BN1106_s789B000476 < 0.0001 0.067 0.000
Rab-18 BN1106_s2036B000204 0.0049 0.000 0.538
Rho GTPase Rac BN1106_s4818B000076 0.12 0.000 0.238
SNAREs
Synaptotagmin BN1106_s3353B000056 0.084 0.121 0.397
Syntaxin 1A BN1106_s1142B000130 0.003 0.078 0.713
Syntaxin-binding protein 1 BN1106_s1187B000336 0.93 0.081 0.077
Synaptotagmin BN1106_s7334B000020 0.00014 0.000 0.353
Synaptotagmin-like protein 4 BN1106_s189B000725 0.92 0.044 0.040
SNAP-25 BN1106_s4176B000102 0.00077 0.000 0.728
SNAP-gamma BN1106_s178B000373 0.95 0.167 0.161
Vesicle transport
Syntenin-1 BN1106_s390B000196 0.0078 0.000 1.535
Syntenin-1 BN1106_s4740B000062 0.0089 0.000 1.703
Autophagy-related protein 9A BN1106_s973B000182 0.0008 0.000 0.193
Pacsin BN1106_s878B000298 0.0011 0.181 0.000
LAMP-1 BN1106_s2489B000362 0.01 0.040 0.296
VPS26 BN1106_s2566B000129 0.00027 0.094 0.000
Membrane structure and remodelling
Annexin B2 BN1106_s500B000161 < 0.0001 1.295 0.573
Annexin BN1106_s819B000365 0.00099 0.195 0.000
Annexin BN1106_s3266B000046 0.02 0.149 0.973
Annexin BN1106_s819B000364 0.033 1.568 1.022
Annexin BN1106_s945B000218 0.032 0.623 0.992
Acid sphingomyelinase BN1106_s1285B000159 0.34 0.690 0.976
Na+/H+ exchange regulatory cofactor BN1106_s2296B000149 0.0013 1.892 0.000
SH3-domain GRB2-like endophilin BN1106_s335B000427 0.23 0.399 0.750
(Continued)
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by immunoblotting. Consistent with our quantitative proteomics data, PDCD6IP, TSG101,
RAL-A and CD63 receptor were all considerably enriched in 120k EVs (Fig 1C). The blots
showed that aSMase and DM9-containing protein were found in both EV sub-types in agree-
ment with the quantitative proteomics analysis; both fell below the significance threshold
(p = 0.05) for enrichment in either EV sub-population (Fig 1B).
Immunofluorescence confirms that the F. hepatica EV sub-populations
have different cellular origins
Adult F. hepatica tissue sections were probed with anti-sera raised against the F. hepatica
CD63 receptor and RAL-A (as markers for the 120k EVs) or cathepsin L1 (as a marker for the
15k EVs) to determine the site of production/release of EVs from the parasite. We have previ-
ously shown that cathepsin L1 is specific for the 15k EVs [10] and, consistent with this, it was
localised solely to vesicles distributed uniformly throughout the gastrodermal cells that line the
fluke gut (Fig 2A). In contrast, clusters of CD63 receptor-positive vesicles were seen in distinct
regions just beneath the gastrodermis (Fig 2B). At higher magnifications, the CD63 receptor-
positive vesicles were observed within branched ducts leading from larger groups of vesicles
and converging on the gastrodermal cell layer (Fig 2D and 2E). Like CD63, RAL-A also local-
ised to clusters of vesicles lying just beneath the gastrodermis in extracellular locations (Fig
3A). Additional fluorescence (not seen with CD63) was observed in the gastrodermal cells (Fig
3A) whilst a faint signal was also detected in the tegumental syncytium and underlying tegu-
mental cells (Fig 3B). No fluorescence was seen from either of these vesicle sub-populations
when sections were probed with pre-immune sera (Figs 2C and 3C).
Lectin microarray profiling of EVs and comparison to FhTeg profiles
A lectin microarray strategy was used to profile the major surface oligosaccharides of 15k and
120k EVs. Since vesicles were screened intact, this allowed surface structures to be assayed in
situ. Accordingly, this makes lectin microarray a particularly powerful method for identifying
molecules as they would be displayed to the host microenvironment in vivo. Profiles obtained
for intact F. hepatica EVs include contributions from not only the surface and transmembrane
glycoproteins, but also glycolipids and glycosaminoglycan components. The 15k and 120k EVs
generated an almost identical lectin-binding profile that was dominated by strong signals
(>5000 RFU above local background) from eleven lectins: SNA-II, ACA, DSA, LEL, Calsepa,
NPA, GNA, HHA, CCA, RCA-I and CAA (Fig 4, S3 Fig). The remaining lectins demonstrated
only low-level interactions with the EVs. In contrast, lectin microarray profiles obtained for
extracted tegument proteins (FhTeg) bound to a broad range of lectins (Fig 4, S3 Fig) albeit at
low intensity for the majority. Two-dimensional, unsupervised hierarchical clustering of the
scale-normalized replicate profile data resulted in a clear division of the EVs vs FhTeg samples
(Fig 4), which indicated that they each displayed either different combinations and/or abun-
dances of glycan structures. In general agreement with the glycoanalysis reported for F.
Table 3. (Continued)
Protein name Gene ID t-test (p value) emPAI 15k emPAI 120k
EHD1 dynamin-like BN1106_s2100B000128 0.86 0.057 0.000
Myoferlin BN1106_s3585B000136 0.015 0.682 1.606
Otoferlin BN1106_s3428B000062 0.00029 0.102 0.931
CD63 antigen BN1106_s4560B000072 0.18 0.048 0.324
Tetraspanin-CD63 receptor BN1106_s1657B000161 0.016 0.207 0.603
https://doi.org/10.1371/journal.pntd.0007087.t003
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hepatica tegumental surface preparations [19], the lectin profiles for both EV sub-populations
suggested the presence of high mannose N-linked structures on the EV surface, through bind-
ing of Calsepa, NPA, GNA and HHA, as well as more diverse and complex structures (poten-
tially components of N- or O-linked protein glycosylation or glycolipid structures) as
suggested by binding of SNA-II, ACA, DSA, LEL, RCA-I and CAA.
Establishment of carbohydrate-mediated EV-lectin binding
To establish that the binding between the lectins and the EVs was indeed carbohydrate medi-
ated, selected sugars (Lac, αManOMe, GlcNAc) were tested as competitive inhibitors of EV
binding. Since the lectin-binding profiles of the 15k and 120k EVs were extremely similar,
only the 120k EVs were used in subsequent microarray experiments. In the presence of Lac,
significant inhibition was observed at lectins SNA-II (-98%, p< 0.01) and RCA-I (-89%,
p< 0.05) (Fig 5, S4 Fig). Significant lectin-binding inhibition was observed in the presence of
αManOMe at Man-binding lectins Calsepa (-92%, p< 0.01) and NPA (-65%, p< 0.05) (Fig 5,
S4 Fig). Man-binding lectins HHA and GNA were not inhibited by αManOMe, but this is con-
sistent with previous reports showing the dependence of HHA and some other lectins upon
multiple residues in an oligosaccharide for specific binding [23]. With GlcNAc, significant
inhibition was observed at lectins LEL (-80%) and WGA (-77%) (both p< 0.01) (Fig 5, S4
Fig 2. CD63 receptor-positive EVs are found in sub-gastrodermal regions of adult F. hepatica. Tissue sections of adult F. hepatica
were probed with anti-cathepsin L (A) or anti-CD63 receptor antibodies (B, D-E) or with rabbit pre-immune serum (C). A. Specific
cathepsin L immunoreactivity (arrows) can be seen within the gastrodermal cells (G) that line the parasite gut. L, gut lumen. B. Strong
CD63 receptor immunolabeling is observed in vesicles that occur as distinct clusters (arrows) just beneath the gastrodermal cell layer.
C. No specific immunofluorescence can be seen in these areas when sections were probed pre-immune control sera. D-E. CD63
receptor-positive vesicles (V) can be seen along duct-like structures (arrows) that converge upon the vesicle clusters in sub-
gastrodermal regions of the adult fluke. Scale bars 25 μm (A-C) or 10 μm (D-E).
https://doi.org/10.1371/journal.pntd.0007087.g002
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Fig). Curiously, signals increased at CAA for the EVs in the presence of Lac, αManOMe and
GlcNAc (Fig 5, S4 Fig). Similarly, signals increased for RCA-I in the presence of αManOMe
and GlcNAc, leading to the speculation of some stabilizing effect generated by the inclusion of
the soluble sugars–either enabling more accessible presentation of the EV surface glycans or
the binding of EV surface-presented adhesion molecules to the protein or carbohydrate com-
ponents of the lectins to which binding intensity was increased.
Modulation of EV-lectin interactions by glycosylation-specific hydrolases
Exo- and endo-glycosidase treatments were set up with PKH26-labelled EVs prior to their pro-
filing by lectin microarray (Fig 6; S5 Fig; S6 Fig). Lectin microarray profiles for EVs treated
with β-galactosidase demonstrated a reduction in binding intensity at SNA-II (-25%, p< 0.01)
and reductions at a number of lectins which demonstrated low intensity EV binding (Fig 6, S5
Fig). ACA, a lectin which recognizes β-linked Gal terminations with a marked preference for
Gal-β(1!3)-GalNAc, demonstrated a strong reduction in signal (-57%) after EVs were treated
with β-galactosidase (Fig 6, S5 Fig). However, RCA-I demonstrated a modest increase in bind-
ing (+14%) instead of the expected decrease (S5 Fig). A number of minor response changes
were also observed across the profile (S5 Fig).
Following from the previous reports of high mannose structures on F. hepatica tegumental
surface proteins [19,24], it was anticipated that α-mannosidase would have a substantial
Fig 3. RAL-A-positive EVs are found in sub-gastrodermal regions and other structures of adult F. hepatica. Tissue
sections of adult F. hepatica were probed with anti-RAL-A antibodies (A-B) or with rabbit pre-immune serum (C). A.
Strong RAL-A immunolabeling is observed in vesicles that occur as distinct clusters (arrows) in extracellular locations
just beneath the gastrodermal cell layer. Specific RAL-A immunoreactivity can be seen within the gastrodermal cells
(G) that line the parasite gut. L, gut lumen. B. Faint immunofluorescence was observed throughout the tegumental
syncytium (T) and in the underlying tegumental cell bodies (arrows). C. No specific immunofluorescence was
observed when sections were probed with pre-immune control sera. Scale bars 50 μm (A) or 7.5 μm (B-C).
https://doi.org/10.1371/journal.pntd.0007087.g003
Fig 4. Comparison of 15k and 120k EV and tegument (Teg) mean lectin microarray responses. Heat map and two-dimensional hierarchical clustering of scale-
normalized lectin microarray profile data for all technical replicates. Data depicted in heat map was scaled to fit a 0–30,000 RFU window and clustered by average
linkage, Euclidean distance method.
https://doi.org/10.1371/journal.pntd.0007087.g004
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impact on EV binding at a subset of lectins that bind to such structures. Surprisingly, however,
only Calsepa and GNA demonstrated modest and insignificant reductions in signal following
α-mannosidase treatment of the FhEVs (Fig 6, S5 Fig). NPA showed an increase in binding
after α-mannosidase treatment (but with high variability across replicates) whilst HHA dem-
onstrated a marginal increase in signal (Fig 6, S5 Fig). Given that incubation conditions were
stabilized to favour the enzyme, this result was highly unexpected.
The endo-β-N-acetylglucosaminidases Endo H and Endo Tv have similar specificity for
high mannose-type N-linked oligosaccharides [21]. Here, these comparable enzymes produced
similar changes in overall EV lectin-binding profiles, although these were very modest (Fig 6).
Endo H produced no significant profile changes for the EVs, except for a substantial increase
in binding at the Type-II N-acetyllactosamine (LacNAc)-specific RCA-I (+51%, p< 0.05)
which was mirrored by Endo Tv at RCA-I (+56%) (Fig 6, S6 Fig). Other lectins which bind to
complex and hybrid, N-linked oligosaccharides, such as PHA-E, PHA-L, PCA and CPA, did
not demonstrate increases in binding after the theoretical removal of the number of high man-
nose structures on the EV surface (although CAA did demonstrate the trend of increased bind-
ing observed with most of the treated EVs) (Fig 6, S6 Fig).
In sharp contrast, to the exo- and endo-glycosidases, the glyco-amidase PNGase F drasti-
cally remodelled the EV lectin microarray profile (Fig 6 and S6 Fig). As the incubation
Fig 5. Competitive inhibition of lectin binding on the 120k EV surface.Arrowheads indicate significant (p� 0.05) mean lectin microarray response changes
imparted by competitive inhibition with 50 mM final concentrations of Lac, αManOMe or GlcNAc as indicated.
https://doi.org/10.1371/journal.pntd.0007087.g005
Fig 6. Comparison of the effects of glycosidase treatment on 120k EV lectin-binding profiles. Heat map of 120k EV mean lectin microarray profiles imparted by
treatment with exo-glycosidases, endo-glycosidases or glyco-amidase in comparison with their respective untreated, pH-adjusted controls. Mean data derived from total
intensity mean adjusted replicate data (mannosidase, galactosidase (n = 5); PNGase F, Endo Tv, Endo H (n = 4); non-enzyme controls adjusted to pH 4.5, pH 5.5, pH 7.4
(n = 3)). All data subjected to two-dimensional hierarchical clustering by average linkage, Euclidean distance method.
https://doi.org/10.1371/journal.pntd.0007087.g006
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conditions were chosen to keep the vesicles intact (no detergents or reducing agents), access to
the amide bond formed between peptides and attached N-linked oligosaccharides may still
have been somewhat restricted. Nonetheless, the changes in profile suggested removal of a
high proportion of the high-mannose glycans and potentially the un-masking of other, pre-
sumably non-N-linked structures which were then able to interact with a number of lectins
(Fig 6, S6 Fig). Specifically, high-mannose binding lectins Calsepa (-45%, p< 0.01), GNA
(-67%, p< 0.01) and HHA (-35%, p< 0.05) demonstrated substantial reductions in intensity
with PNGase F-treated EVs in comparison to the pH 7.4 (no enzyme) negative control (Fig 6,
S6 Fig). Lectins ACA, PNA, GS-I-A4, DSA, LcH B, MAA, SNA-I, CCA, PHA-L and GS-I-B4
all demonstrated some degree of signal increase with PNGase F-treated EVs in comparison to
their untreated counterparts (Fig 6, S6 Fig) suggesting an unmasking of structures through the
removal of longer N-linked oligosaccharides.
Internalisation of F. hepatica EVs by macrophages is blocked by
glycosidase treatment
To investigate the role of carbohydrates displayed on the EV outer surface in vesicle uptake,
PKH26-labelled F. hepatica EVs were pre-incubated with PNGase F or Endo H and added to
RAW246.7 macrophages in culture. Non-modified EVs were readily taken up by the cells and
could be seen as discrete areas of red fluorescence evenly dispersed throughout the cytoplasm
(Fig 7A; S7 Fig). Treatment of cells with cytochalasin D (a blocker of actin polymerisation and
endocytosis pathways) inhibited EV internalisation confirming that uptake is an active process
(S8 Fig). Similarly, cells incubated with the glycosidase-treated EVs showed reduced red fluo-
rescence suggesting that de-glycosylation of the EVs blocked their uptake by macrophages (p
range< 0.001 to< 0.05; Fig 7B). Treatment of EVs with exo-glycosidases (α1–2,3 mannosi-
dase and β1–4 galactosidase) did not have any effect on EV uptake by macrophages (S9 Fig) in
agreement with the inability of these enzymes to significantly alter the profile of carbohydrates
displayed on the EV surface.
Internalisation of F. hepatica EVs by macrophages is enhanced in the
presence of host antiserum and antibodies prepared against specific EV
surface proteins
We next examined the role of surface-exposed proteins in vesicle uptake by host cells. Western
blot analysis, using serum samples taken from rats, experimentally infected with F. hepatica,
showed that both the 15k and 120k EVs induced a host antibody response as early as 7 days
post-infection. This response intensified as the infection progressed with the strongest
response seen at 21 days post-infection which corresponds to the migration of the fluke
through the liver parenchyma in the rat model (Fig 8A). We then tested the effect of these host
antibodies on the uptake of F. hepatica EVs by macrophages. The 15k and 120k EVs were
stained with the lipophilic dye PKH26 and incubated with rat pre-infection serum or sera
taken at 21 days and 70 days post-infection. Unbound antibodies were removed by centrifuga-
tion and the EVs were incubated with RAW246.7 macrophages for 3 h at 37˚C before the cells
were analysed by confocal microscopy. When pre-treated with rat pre-infection serum, the
EVs were internalised by the macrophages as shown by discrete, punctate regions of red fluo-
rescence that were observed throughout the cytoplasm (Fig 8B; S7 Fig). However, when pre-
treated with 21-day post-infection rat serum the internalisation of the 120k EVs increased sig-
nificantly (p< 0.01; Fig 8C). A similar, but less dramatic, effect was observed when EVs were
pre-treated with the 70-day serum (p< 0.05; Fig 8C) consistent with the level of antibody
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response seen by Western blotting (Fig 8A). Similar effects on uptake were observed using the
15k EVs (S7 Fig).
To investigate the functional role of individual EV surface proteins, the PKH26-labelled
vesicles were incubated with antibodies raised against specific surface proteins. These were
selected from the 380 proteins identified following biotin pulldown as either potential ligands
for receptor-mediated endocytosis (CD63 receptor and DM9-containing protein) having roles
in EV biogenesis and trafficking (aSMase) or suspected fusogenic properties (myoferlin). The
antibody-treated EVs were again added to RAW264.7 macrophages for 3 h at 37˚C and the
cells were analysed by confocal microscopy (Fig 9A). As observed with the rat serum, pre-
treatment of labelled 120k EVs with antibodies raised against DM9-containing protein, myo-
ferlin (p< 0.001), and CD63 receptor (p< 0.05) resulted in a greater level of internalisation by
macrophages compared to control EVs (Fig 9B). Similar effects on internalisation were
observed when 15k EVs were pre-incubated with antibodies raised against DM9-containing
protein, myoferlin and aSMase (S7 Fig).
Discussion
There is considerable interest in EVs as vehicles for the transfer of parasite-derived molecules
to host cells. Many researchers have successfully used proteomics techniques to identify their
resident proteins [9,10,25–27] and, therefore, we have a good working knowledge of the EV
cargo proteins and are beginning to understand those involved in EV biogenesis and traffick-
ing pathways [10,13]. By contrast, little is known about the molecules that modify the surface
Fig 7. De-glycosylation of F. hepatica EVs blocks their internalisation by host macrophages. (A) RAW264.7 macrophages were incubated
with PKH26-labelled 120k EVs for 3 h at 37˚C and the cells were analysed by confocal microscopy. (B) Pre-treatment of labelled EVs with the
glycosidases PNGase F and Endo H significantly reduced the uptake of the EVs when measured as fluorescence intensity relative to cells
incubated with untreated EVs.
https://doi.org/10.1371/journal.pntd.0007087.g007
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of parasite EVs. Since these molecules likely make contact with receptors on the host cell
plasma membrane (initiating their endocytosis), they would be obvious targets for interven-
tions that aim to prevent parasite EV-host cell interaction. In this study we have profiled the
proteins and oligosaccharides exposed on the surface of the 15k and 120k F. hepatica EVs
which has revealed a great deal about how EVs are formed and trafficked by this parasite but
also how they interact with recipient host cells.
Fig 8. Host antiserum enhances internalisation of F. hepatica EVs by macrophages. (A) Immunogenicity of F.
hepatica EVs in F. hepatica-infected rats. Equal amounts (10μg total protein) of 15k and 120k EVs were analysed by
Western blot using pre-infection (PI) sera and serum samples taken 7, 21 and 70 days post-infection. (B) RAW264.7
macrophages were incubated with PKH26-labelled 120k EVs for 3 h at 37˚C and the cells were analysed by confocal
microscopy. EVs pre-incubated with pre-infection rat serum were internalised by the macrophages as shown by the
punctate red fluorescence observed throughout the cytoplasm. However, when EVs were pre-treated with 21-day rat
serum the internalisation the EVs increased considerably. A similar, but less dramatic, effect was observed when EVs
were pre-treated with the 70-day serum. Nuclei were stained with DAPI (blue). (C) These effects were statistically
significant when measured as fluorescence intensity relative to cells treated with EVs pre-incubated with pre-infection
serum.
https://doi.org/10.1371/journal.pntd.0007087.g008
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Cells release different populations of EVs, which may either bud directly from their plasma
membrane (microvesicles) or derive from the endosomal pathway (exosomes). In keeping
with our previous studies, analysis of the 120k F. hepatica EVs revealed an enrichment in mol-
ecules of the endosomal sorting complex required for transport (ESCRT) pathway, the main
driver of exosome formation in mammalian cells [28], suggesting an endosomal origin for
these vesicles [10]. These included members of the ESCRT-III complex and the Vps4 ATPase
responsible for intra-luminal vesicle budding and abscission, respectively, as well as the
ESCRT-associated proteins ALIX and syntenin. Other proteins that provide further support
for an endosomal origin of the parasite 120k EVs include STAM-binding protein and TSG101,
(ESCRT-0 and ESCRT-I components, respectively), as well as a number of SNAREs and Rab
GTPases. These molecules are involved in vesicle trafficking by bringing opposing membranes
together and catalysing their fusion [29] and have important roles in exosome biogenesis and
secretion [30]. Their presence on the surface of F. hepatica EVs may simply be a remnant car-
ried over from their endosomal origins but they could also mediate tethering and fusion of the
parasite EVs with membrane-bound organelles following their endocytosis by host cells.
The tetraspanin annotated as CD63 receptor is a trematode-specific membrane protein [10]
whilst RAL-A is a small GTPase required for MVB biogenesis and EV release in Caenorhabdi-
tis elegans [31]. Since both are highly enriched in F. hepatica 120k EVs, compared to the 15k
EV population, we employed anti-CD63 and anti-RAL-A antibodies in immunofluorescence
studies to locate the origin of the 120k EVs in adult parasites. Surprisingly, distinct clusters of
Fig 9. Antibodies raised against specific F. hepatica EV surface proteins also influence uptake by macrophages. (A) RAW264.7 macrophages were
incubated with PKH26-labelled 120k EVs for 3 h at 37˚C and the cells were analysed by confocal microscopy. Pre-treatment of labelled EVs with
antibodies raised against specific F. hepatica proteins (DM9, myoferlin and CD63 receptor) resulted in a greater level of internalisation by
macrophages compared to control EVs (left panels). (B) Internalisation of myoferlin- and CD63 receptor-treated EVs was statistically significant when
measured as fluorescence intensity relative to cells incubated with untreated EVs.
https://doi.org/10.1371/journal.pntd.0007087.g009
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vesicles, showing both CD63 receptor and RAL-A immunostaining were observed just beneath
the gastrodermis. CD63-labelled vesicles were also seen within “Y-branched” ducts, character-
istic of the liver fluke protonephridial (excretory) system described many years ago by Pante-
louris and Threadgold [32] whilst RAL-A vesicles lay in similar extracellular locations.
Interestingly, the ducts appeared to converge upon the gastrodermis suggesting that they may
drain into the gut lumen, a scenario also deemed possible for the protonephridial system of
free-living planarians [33]. RAL-A is a multifunctional GTPase with varied roles in vesicle traf-
ficking [34] so it was perhaps not surprising that it was found associated with the tegument
and gut, both of which are major sites of secretion in the parasite.
The 15k EVs were localised to the gastrodermal cells that line the parasite gut in keeping
with our previous ultrastructural observations [10]. This tissue-specific distribution, together
with the enrichment of saposin (previously shown to lyse host erythrocytes; [35]) and prote-
ases, such as cathepsin L1, cathepsin L2 and an aspartic protease, that can efficiently degrade
host haemoglobin in F. hepatica and other trematodes [36,37] strongly suggests a digestive
function for the 15k EVs. Following ultrastructural examination of the F. hepatica gut, Halton
[38] suggested that the numerous secretory vesicles held with the gastrodermal cells are
released into the lumen of the gut upon rupture of the apical plasma membrane. The stimulus
for this periodic mass release appears to be the presence of food in the gut and the enrichment
of numerous calcium-binding/sensing molecules (including F. hepatica calcium-binding pro-
tein 4, calmodulins, calreticulin and EF-hand domain proteins) in the 15k EVs suggests that
calcium signalling pathways may regulate this process.
We previously used trypsin-shaving (and subsequent sequential membrane extraction) to
identify surface-exposed and membrane-associated proteins of intact F. hepatica 120k EVs
[10]. Using the current biotinylation approach, we identified a further 111 surface proteins
that were not found in the earlier study. Sixty of these (54%; dominated by vesicle trafficking
proteins and pumps/transporters) are reported to be membrane proteins based on GO terms
or experimental evidence in the literature. A number of cytosolic proteins and digestive
enzymes, such as cathepsin B and L peptidases, were also found amongst the EV surface pro-
teins. Although unexpected, it is not unusual for cytoplasmic/soluble proteins to be found on
the EV surface. Indeed, a recent study showed that 51.1% of proteins found on the surface of
EVs derived from mast cells were cytosolic [39]. Whilst these could be artefacts we applied
very stringent protein acceptance criteria in order to eliminate non-specific contaminants dur-
ing affinity-purification of biotinylated EV proteins. A more likely explanation, in agreement
with Cvjetkovic et al. [39], is that the cytosolic/soluble proteins adhere to the surface and co-
purify with the EVs. Since cathepsins and EVs are co-secreted from the fluke in vivo this asso-
ciation could be real. In our earlier study of F. hepatica EVs we observed that most cathepsins
were recovered from carbonate washes of the EV membrane [10] suggesting that they make
electrostatic interactions with the EV surface and may only adhere upon secretion from the
parasite.
Whilst our proteomics analysis showed clear enrichment of proteins associated with the
15k and 120k EV sub-populations, it is likely that some level of heterogeneity will occur due to
the ultracentrifugation method used to isolate them. However, Kowal et al. [40] found that
molecules considered to be “classic” exosome markers, such as CD63, are also present on
larger vesicles secreted by human dendritic cells (i.e. microvesicles that are typically recovered
following 10–15,000 x g centrifugation of cell culture media). Thus, it could be a worthwhile
exercise to exploit antibodies to a wider array of molecules to classify the various cellular/tissue
origins of helminth EVs and to track their trafficking and release.
In addition to characterising the F. hepatica EV surface proteome, we used recently devel-
oped methods [20] to profile the major oligosaccharides displayed on the EV surface as a first
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step towards understanding the role of glycoconjugates in the host-parasite relationship. The
approach of using intact EVs allowed a more biologically relevant scenario for profiling
ligand/receptor arrangement on the surface of membranes compared to profiling distinct mol-
ecules in isolation. Comparative lectin-binding data demonstrated that the F. hepatica EV and
tegumental (FhTeg) profiles are distinct from one another; the EV profiles are more ‘punctu-
ated’ by strong responses at fewer lectins whilst the extracted FhTeg protein population bound
to a greater number of different lectins. These findings suggest that either F. hepatica EVs dis-
play less overall oligosaccharide diversity on their surface or that select, extended structures
dominate the EV surface and mask shorter underlying structures. Overall, these data, together
with our immunofluorescence studies, support our idea that both the 15k and 120k EVs are
selectively synthesised and secreted by the parasites and are not simply derived from shedding
or blebbing of the surface tegument [10,13].
In this work, modulation of EV-lectin binding patterns was possible through both competi-
tive inhibition with sugars and by specific enzymatic manipulation. Several of the interactions
between the lectins and EVs could be selectively and sharply inhibited with αManOMe,
GlcNAc or Lac, demonstrating that they were, indeed, mediated by carbohydrates present on
the F. hepatica EV surface. Some evidence of carbohydrate-specific enzymatic sensitivity was
observed for the intact EVs, but the changes generated, even after extended exposure to select
enzymes, were relatively modest except for those following treatment with the glyco-amidase
PNGase F.
Lectin microarrays also demonstrated that the F. hepatica EV surface is predominated by
mannose-bearing glycoconjugates. Despite this, exposure to exo-α-mannosidase, a broad-
spectrum enzyme that hydrolyses Man residues connected in α-(1!2, 3 and 6) linkages, only
subtly altered the binding profile of the EVs. The lack of substantial alteration of the lectin
microarray profile by Endo Tv and Endo H was also unexpected since PNGase F produced a
significant revision of the EV-lectin microarray profile, even at lectins which are reported to
recognize mannose and mannose-containing oligosaccharides. Collectively, these studies sug-
gest a condition of the presentation of high-mannose, N-linked oligosaccharides that does not
allow hydrolysis by the selected endo-glycosidases but does permit their removal with the
glyco-amidase. A growing number of studies suggest that unusual or truly novel oligosaccha-
ride structures (including di- and tri-fucosyl substitution of GlcNAc residues in the chitobiose
core of N-linked glycans or inclusion of phophorylcholine or fucosylation and/or xylosylation
at the non-reducing end) are common features of helminth glycomes [41–43] which may
explain the resistance of F. hepatica EV surface proteins to exo- and endo-glycosidases that are
commonly used to modify mammalian structures. The biological significance of this remains
to be elucidated, although having N-linked oligosaccharides that are resistant to degradation
may be beneficial to the parasite by allowing prolonged biological activity of the EVs in the
parasite-host microenvironment.
The primary mechanism for uptake of parasite EVs by recipient cells appears to be via
endocytosis [25,44]. However, an alternative fate for parasite-derived EVs was recently
described for the protozoan Trypanosoma brucei whereby their cargo was delivered directly
into the host cell cytoplasm following fusion of the EVs with the plasma membrane [45].
Although, this mechanism of delivery has yet to be reported for helminth-derived vesicles it
was of interest that we discovered several molecules on the surface of F. hepatica EVs with
potential fusogenic properties, i.e. the ability to merge phospholipid bilayers. Two of these,
myoferlin (enriched in the 120k EVs) and EHD1 (dynamin-like; unique to 15k EVs), have
been shown to promote fusion of myoblast plasma membranes [46,47], whilst myoferlin-
depleted mammalian exosomes are taken up less efficiently by target cells [48]. A third mole-
cule, GAPDH (unique to the 120k EVs; [10]), in addition to its established role in glycolysis,
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also has potent fusogenic properties and can merge plasmenylethanolamine-containing phos-
pholipid bilayers [49,50]. Recent work has shown that the EVs released by the nematode Helig-
mosomoides polygyrus are enriched in similar specialised phospholipids [51].
Conceivably, EV surface-expressed fusogenic molecules, or other molecules that serve as
ligands for host cell surface receptors, could be targeted to disrupt parasite EV-host cell inter-
actions. Indeed, treatment of EVs derived from adult Opisthorchis viverrini, a trematode para-
site related to F. hepatica, with anti-tetraspanin antibodies blocks their uptake by
cholangiocytes in vitro [25] which provides proof-of-concept for this strategy. However, we
observed that pre-treatment of both the F. hepatica 15k and 120k EVs with sera obtained from
infected rat hosts significantly enhanced their uptake by macrophages in vitro with the level of
internalisation correlating with the immunoreactivity of the serum against the EVs (21 days
post-infection > 70 days post-infection). Enhanced uptake was also observed using purified
antibodies raised against several specific EV surface proteins including DM9-containing pro-
tein, myoferlin, aSMase and CD63 receptor (not a direct homolog of the CD63 targeted in O.
viverrini). These unexpected findings are in agreement with a recent study in which host anti-
sera increased the uptake of H. polygyrus EVs by macrophages [44], presumably via opsonisa-
tion. The authors suggested that FcR-mediated uptake directs the parasite EVs into lysosomes
where they are presumably degraded thus losing any functional effects on host cells. Whilst
this may indeed be an appropriate host defence strategy, aimed at disarming the parasite’s
immunomodulatory capabilities, delivery of some F. hepatica molecules to the endolysosomal
system may, in fact, benefit the parasite; e.g. we have shown that HDM impairs antigen pro-
cessing by macrophages via inhibition of lysosomal vATPase [6] and cathepsin L1 (which is
resistant to lysosomal degradation) degrades TLR3 within the endosome [5]. Thus, caution
should be taken when designing potential EV blocking agents as these may work with some,
but not all, host cell types.
Here we have employed a novel approach to provide a comprehensive analysis of the pro-
teins and oligosaccharides exposed on the surface of two sub-populations of F. hepatica EVs
and demonstrated their importance in interactions with host cells. As our knowledge of the
biological effects and practical uses of parasite EVs continues to grow, our findings may be
used to direct the selection of anti-parasite vaccine candidates or to aid design of agents that
may be used therapeutically to block parasite-derived EV function.
Supporting information
S1 Table. Proteins identified on the surface of F. hepatica EVs by mass spectrometry.
(XLSX)
S1 Fig. Surface biotinylation of F. hepatica EVs and streptavidin pulldown workflow. F.
hepatica 15k and 120k EVs were incubated with a non-permeable biotin reagent. The EVs
were solubilised with detergent and the biotinylated surface proteins recovered using a strepta-
vidin affinity column.
Western blot with streptavidin conjugated with alkaline phosphatase showing the profile of
biotinylated protein after sequential extraction. E1-E3, represent each extraction step. Biotiny-
lated proteins are purified with high efficiency after the pull-down with streptavidin agarose
beads (B) whilst non-biotinylated proteins are lost in the flow-through (S).
(TIF)
S2 Fig. Enrichment of GO terms (A) and protein domains (B) for the proteins identified on
the surface of the 15k and 120k EVs.
(TIF)
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S3 Fig. Bar chart comparing relative lectin microarray responses generated for 15k and
120k EVs and tegument samples. Data subjected to total intensity mean normalization. Error
bars represent +/- one standard deviation.
(TIF)
S4 Fig. Bar charts detailing competitive inhibition of lectin binding on the 120k EV sur-
face. 120k EV mean lectin microarray response changes imparted by competitive inhibition
with 50 mM final concentrations of A. Lac, B. αManOMe and C. GlcNAc. Error bars represent
+/- one standard deviation based on three technical replicates. Significance of inhibition �
p� 0.05; �� p� 0.01.
(TIF)
S5 Fig. Effect of exo-glycosidase treatment on lectin-binding at the EV surface. A. 120k EV
mean lectin microarray responses imparted by exo-glycosidase treatment with (A) β-galactosi-
dase (n = 5) and (B) α-mannosidase (n = 5) and their respective pH-matched controls (con-
trols n = 3). Error bars represent one +/- standard deviation.
(TIF)
S6 Fig. Effect of endo-glycosidase treatment on lectin-binding at the EV surface. 120k EV
mean lectin microarray responses imparted by treatment with endo-glycosidases A. Endo H
(n = 4) and B. Endo Tv (n = 4) and glyco-amidase C. PNGase F (n = 4) and their respective
pH-matched controls (all n = 3). Error bars represent +/- one standard deviation.
(TIF)
S7 Fig. Uptake of 15k EVs by macrophages. RAW264.7 macrophages were incubated with
PKH26-labelled 15k EVs for 3 h at 37˚C and the cells were analysed by confocal microscopy.
(A) Pre-treatment of labelled EVs with the glycosidases PNGase F and Endo H considerably
reduced their uptake. (B) Pre-treatment of labelled EVs with 21-day rat serum increased the
internalisation of the EVs considerably. A similar, but less dramatic, effect was observed when
EVs were pre-treated with the 70-day serum. (C) Pre-treatment of labelled EVs with antibodies
raised against specific F. hepatica proteins (DM9, myoferlin and aSMase) resulted in a greater
level of internalisation by macrophages compared to control EVs (left panel).
(TIF)
S8 Fig. Uptake of 120k EVs by macrophages is inhibited by cytochalasin D. RAW264.7
macrophages were incubated with PKH26-labelled 120k EVs for 3 h at 37˚C and the cells were
analysed by confocal microscopy. Co-incubation of cells with cytochalasin D (2μg/ml) inhib-
ited uptake of EVs.
(TIF)
S9 Fig. Uptake of 120k EVs by macrophages is not effected by exo-glycosidases. RAW264.7
macrophages were incubated with PKH26-labelled 120k EVs for 3 h at 37˚C and the cells were
analysed by confocal microscopy. Pre-treatment of labelled EVs with the exo-glycosidases α1–
2,3 mannosidase and β1–4 galactosidase had no effect on the uptake of the EVs.
(TIF)
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